FindTrial
Sign In

A comparative clinical study of dusting two ayurvedic powders after therapeutic bloodletting in diabetic foot ulcer

A comparative clinical study of Rajani dwaya Churna and Kaseesadi Churna Avachurnana after Sira Vyadhana in Dustavrana –W.S.R. to diabetic foot ulcer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070324
Enrollment
100
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Dr Santosh Ramachandra Naik
Lead Sponsor
Shri Veer Pulikeshi Rural Ayurvedic Mediclal College Hospital and Research Centre Badami
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. As per Wagner classification, Ulcers of Diabetic foot with Grade 1-superficial ulcers involving full skin thickness, 2. Patients on medications with well controlled diabetes mellitus. (HbA1c less than 7 )

Exclusion criteria

Exclusion criteria: 1. As per Wagner classification diabetic foot Ulcer with .Grade 2-Deep ulcers penetrating down to ligaments and muscle but no bone involvement Grade 3- Deep ulcers with cellulitis or abscess formation often with osteomyelitis Grade 4- Localized gangrene Grade 5- Extensive Gangrene involving the whole foot. 2. Patients with disorders like Malignancy, Tuberculosis, Leprosy, HIV and HbsAg

Design outcomes

Primary

MeasureTime frame
To evaluate the Efficacy of Rajanidwaya Churna and KaseesadiChurna Avachurnana after Sira Vyadhana in the reduction of DustaVrana lakshanas like Pain, Itching, Size of ulcer, Discharge and Foul smellTimepoint: at baseline and 30th day of treatment—

Secondary

MeasureTime frame
To evaluate the Ropana effect of Rajanidwaya Churna & KaseesadiChurna Avachurnana after Sira Vyadhana in DustaVrana.Timepoint: At baseline, 15th day & 30th day of treatment—

Countries

India

Contacts

Public ContactDr N H Kulkarni

B M J Ayurvedic Medical College, Gajendragad, Gadag (Dist)-582114

drnhk75@gmail.com9449188822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026